Table 1 Open in new tab Laboratory...

Laboratory parameters

Observed values

Reference range

On admission

WBC

4100

3300–8600

/µL

Neutrophil

61.0

40.0–71.0

Lymphocyte

22.0

26.0–47.0

Eosinophil

0.0

Atypical lymphocyte

11.0

0.0–0.0

12.3

11.6–14.8

g/dL

37.2

35.1–44.4

Plt

11.7

15.8–34.8

×10⁴/µL

APTT

42.3

26.0–38.0

PT-INR

1.11

0.85–1.15

D-dimer

5.7

<1.0

µg/mL

AST

154

13–30

U/L

ALT

7–23

U/L

LDH

973

124–222

U/L

ALP

38–113

U/L

ɤ-GTP

9–32

U/L

T-bil

0.5

0.4–1.5

mg/dL

6.2

6.6–8.1

g/dL

Alb

2.6

4.1–5.1

g/dL

BUN

13.4

8–20

mg/dL

0.64

0.46–0.79

mg/dL

eGFR

96.2

≥60

mL/min/1.73 m²

133

138–145

mmol/L

3.9

3.6–4.8

mmol/L

104

101–108

mmol/L

1283

41–153

U/L

CK-MB

≤12

U/L

Glucose

73–109

mg/dL

CRP

8.4

≤0.14

mg/dL

554

28–149

mg/dL

Ferritin

2355

5–152

mg/mL

sIL-2R

2209.7

156.6–474.5

U/mL

Troponin-I

3418

≤24

pg/mL

BNP

200.2

≤18.4

pg/mL

<15

IU/mL

73–138

mg/dL

27.2

11–31

mg/dL

CH50

51.2

25–51

U/mL

Anti-nuclear antibody

>2560, Sp

<40

Anti-dsDNA antibody

(−)

Anti-DNA antibody

(−)

Anti-Sm antibody

(−)

Anti-RNP antibody

>550

<10

IU/mL

Anti-SS-A antibody

(−)

Anti-cardiolipin antibody

(−)

Lupus anticoagulant

(−)

Coombs test

(−)

C-ANCA

(−)

P-ANCA

(−)

TSH

5.1

0.61–4.23

mIU/L

FT3

1.4

2.3–4.0

pg/mL

FT4

1.1

0.9–1.7

ng/dL

IgG

1887

861–1747

mg/dL

IgA

93–393

mg/dL

IgM

50–269

mg/dL

COVID-19 PCR

(−)

Influenza A PCR

(−)

Influenza B PCR

(−)

VCA-IgG

Fold

VCA-IgA

<10

Fold

EBNA

(−)

CMV-IgG

(−)

CMV-IgM

(−)

Coxsackie A9

Fold

Coxsackie B1

Fold

Coxsackie B2

Fold

Coxsackie B3

Fold

Coxsackie B4

Fold

Coxsackie B5

Fold

Coxsackie B6

Fold

Echo 6

Fold

Echo 9

Fold

Echo 16

Fold

Echo 30

Fold

Parvovirus B19

(−)

Rubella-IgG

12.5

EIA

Rubella-IgM

<0.80

Index

Adenovirus

Fold

RS virus

Fold

Parainfluenza 1

<10

Fold

Parainfluenza 2

<10

Fold

Parainfluenza 3

Fold

Two months later

VCA-IgG

Fold

VCA-IgA

<10

Fold

EBNA

(−)

Echo 6

Fold

Parainfluenza 3

Fold

Table 1

Open in new tab

Laboratory findings and results of comprehensive viral testing

Laboratory parameters	Observed values	Reference range
On admission
WBC	4100	3300–8600	/µL
Neutrophil	61.0	40.0–71.0	%
Lymphocyte	22.0	26.0–47.0	%
Eosinophil	0.0		%
Atypical lymphocyte	11.0	0.0–0.0	%
Hb	12.3	11.6–14.8	g/dL
Ht	37.2	35.1–44.4	%
Plt	11.7	15.8–34.8	×10⁴/µL
APTT	42.3	26.0–38.0	s
PT-INR	1.11	0.85–1.15
D-dimer	5.7	<1.0	µg/mL
AST	154	13–30	U/L
ALT	72	7–23	U/L
LDH	973	124–222	U/L
ALP	50	38–113	U/L
ɤ-GTP	68	9–32	U/L
T-bil	0.5	0.4–1.5	mg/dL
TP	6.2	6.6–8.1	g/dL
Alb	2.6	4.1–5.1	g/dL
BUN	13.4	8–20	mg/dL
Cr	0.64	0.46–0.79	mg/dL
eGFR	96.2	≥60	mL/min/1.73 m²
Na	133	138–145	mmol/L
K	3.9	3.6–4.8	mmol/L
Cl	104	101–108	mmol/L
CK	1283	41–153	U/L
CK-MB	14	≤12	U/L
Glucose	93	73–109	mg/dL
CRP	8.4	≤0.14	mg/dL
TG	554	28–149	mg/dL
Ferritin	2355	5–152	mg/mL
sIL-2R	2209.7	156.6–474.5	U/mL
Troponin-I	3418	≤24	pg/mL
BNP	200.2	≤18.4	pg/mL
RF	23	<15	IU/mL
C3	87	73–138	mg/dL
C4	27.2	11–31	mg/dL
CH50	51.2	25–51	U/mL
Anti-nuclear antibody	>2560, Sp	<40
Anti-dsDNA antibody	(−)	(−)
Anti-DNA antibody	(−)	(−)
Anti-Sm antibody	(−)	(−)
Anti-RNP antibody	>550	<10	IU/mL
Anti-SS-A antibody	(−)	(−)
Anti-cardiolipin antibody	(−)	(−)
Lupus anticoagulant	(−)	(−)
Coombs test	(−)	(−)
C-ANCA	(−)	(−)
P-ANCA	(−)	(−)
TSH	5.1	0.61–4.23	mIU/L
FT3	1.4	2.3–4.0	pg/mL
FT4	1.1	0.9–1.7	ng/dL
IgG	1887	861–1747	mg/dL
IgA	99	93–393	mg/dL
IgM	55	50–269	mg/dL
COVID-19 PCR	(−)	(−)
Influenza A PCR	(−)	(−)
Influenza B PCR	(−)	(−)
VCA-IgG	40		Fold
VCA-IgA	<10		Fold
EBNA	(−)	(−)
CMV-IgG	(−)	(−)
CMV-IgM	(−)	(−)
Coxsackie A9	<4	<4	Fold
Coxsackie B1	<4	<4	Fold
Coxsackie B2	<4	<4	Fold
Coxsackie B3	<4	<4	Fold
Coxsackie B4	<4	<4	Fold
Coxsackie B5	<4	<4	Fold
Coxsackie B6	<4	<4	Fold
Echo 6	8	<4	Fold
Echo 9	<4	<4	Fold
Echo 16	<4	<4	Fold
Echo 30	<4	<4	Fold
Parvovirus B19	(−)	(−)
Rubella-IgG	12.5		EIA
Rubella-IgM	<0.80		Index
Adenovirus	<4	<4	Fold
RS virus	<4	<4	Fold
Parainfluenza 1	<10	<4	Fold
Parainfluenza 2	<10	<4	Fold
Parainfluenza 3	40	<4	Fold
Two months later
VCA-IgG	40		Fold
VCA-IgA	<10		Fold
EBNA	(−)	(−)
Echo 6	4	<4	Fold
Parainfluenza 3	40	<4	Fold

Laboratory parameters	Observed values	Reference range
On admission
WBC	4100	3300–8600	/µL
Neutrophil	61.0	40.0–71.0	%
Lymphocyte	22.0	26.0–47.0	%
Eosinophil	0.0		%
Atypical lymphocyte	11.0	0.0–0.0	%
Hb	12.3	11.6–14.8	g/dL
Ht	37.2	35.1–44.4	%
Plt	11.7	15.8–34.8	×10⁴/µL
APTT	42.3	26.0–38.0	s
PT-INR	1.11	0.85–1.15
D-dimer	5.7	<1.0	µg/mL
AST	154	13–30	U/L
ALT	72	7–23	U/L
LDH	973	124–222	U/L
ALP	50	38–113	U/L
ɤ-GTP	68	9–32	U/L
T-bil	0.5	0.4–1.5	mg/dL
TP	6.2	6.6–8.1	g/dL
Alb	2.6	4.1–5.1	g/dL
BUN	13.4	8–20	mg/dL
Cr	0.64	0.46–0.79	mg/dL
eGFR	96.2	≥60	mL/min/1.73 m²
Na	133	138–145	mmol/L
K	3.9	3.6–4.8	mmol/L
Cl	104	101–108	mmol/L
CK	1283	41–153	U/L
CK-MB	14	≤12	U/L
Glucose	93	73–109	mg/dL
CRP	8.4	≤0.14	mg/dL
TG	554	28–149	mg/dL
Ferritin	2355	5–152	mg/mL
sIL-2R	2209.7	156.6–474.5	U/mL
Troponin-I	3418	≤24	pg/mL
BNP	200.2	≤18.4	pg/mL
RF	23	<15	IU/mL
C3	87	73–138	mg/dL
C4	27.2	11–31	mg/dL
CH50	51.2	25–51	U/mL
Anti-nuclear antibody	>2560, Sp	<40
Anti-dsDNA antibody	(−)	(−)
Anti-DNA antibody	(−)	(−)
Anti-Sm antibody	(−)	(−)
Anti-RNP antibody	>550	<10	IU/mL
Anti-SS-A antibody	(−)	(−)
Anti-cardiolipin antibody	(−)	(−)
Lupus anticoagulant	(−)	(−)
Coombs test	(−)	(−)
C-ANCA	(−)	(−)
P-ANCA	(−)	(−)
TSH	5.1	0.61–4.23	mIU/L
FT3	1.4	2.3–4.0	pg/mL
FT4	1.1	0.9–1.7	ng/dL
IgG	1887	861–1747	mg/dL
IgA	99	93–393	mg/dL
IgM	55	50–269	mg/dL
COVID-19 PCR	(−)	(−)
Influenza A PCR	(−)	(−)
Influenza B PCR	(−)	(−)
VCA-IgG	40		Fold
VCA-IgA	<10		Fold
EBNA	(−)	(−)
CMV-IgG	(−)	(−)
CMV-IgM	(−)	(−)
Coxsackie A9	<4	<4	Fold
Coxsackie B1	<4	<4	Fold
Coxsackie B2	<4	<4	Fold
Coxsackie B3	<4	<4	Fold
Coxsackie B4	<4	<4	Fold
Coxsackie B5	<4	<4	Fold
Coxsackie B6	<4	<4	Fold
Echo 6	8	<4	Fold
Echo 9	<4	<4	Fold
Echo 16	<4	<4	Fold
Echo 30	<4	<4	Fold
Parvovirus B19	(−)	(−)
Rubella-IgG	12.5		EIA
Rubella-IgM	<0.80		Index
Adenovirus	<4	<4	Fold
RS virus	<4	<4	Fold
Parainfluenza 1	<10	<4	Fold
Parainfluenza 2	<10	<4	Fold
Parainfluenza 3	40	<4	Fold
Two months later
VCA-IgG	40		Fold
VCA-IgA	<10		Fold
EBNA	(−)	(−)
Echo 6	4	<4	Fold
Parainfluenza 3	40	<4	Fold

(+) means positive test; (−) means negative test.

WBC, white blood cell; Hb, haemoglobin; Ht, haematocrit; Plt, platelet; APTT, activated partial thromboplastin time; PT-INR, prothrombin time and international normalized ratio; AST, aspartate aminotransferase; ALT, alanine aminotransferase; LDH, lactate dehydrogenase; ALP, alkaline phosphatase; ɤ-GTP, gamma-glutamyl transpeptidase; T-bil, total bilirubin; TP, total protein; Alb, albumin; BUN, blood urea nitrogen; Cr, creatinine; eGFR, estimated glomerular filtration rate; Na, sodium; K, potassium; Cl, chlorine; CK, creatinine kinase; CK-MB, creatinine kinase myocardial band; CRP, C-reactive protein; TG, triglyceride; sIL-2R, soluble interleukin-2 receptor; BNP, brain natriuretic peptide; RF, rheumatoid factor; C-ANCA, cytoplasmic-anti-neutrophil cytoplasmic antibody; P-ANCA, perinuclear–anti-neutrophil cytoplasmic antibody; TSH, thyroid stimulating hormone; COVID-19, coronavirus disease 2019; PCR, polymerase chain reaction; VCA, virus capsid antigen; Ig, immunoglobulin; EBNA, Epstein–Barr virus nuclear antigen; CMV, cytomegalovirus; EIA, enzyme immunoassay.

This Feature Is Available To Subscribers Only